Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2

Virology

Volumn 233, Issue 1, 1997, Pages 174-184

  Manchester, Marianne ^a   Gairin, Jean Edouard ^a   Patterson, John B ^a   Alvarez, Jose ^b   Liszewski, M Kathryn ^b   Eto, Danelle S ^a   Atkinson, John P ^b   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; HEMAGGLUTININ; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN;

ARTICLE; CELL ADHESION; CELL SURFACE; CONSENSUS SEQUENCE; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

MEASLES VIRUS; SUGARCANE RAMU STUNT DISEASE PHYTOPLASMA;

EID: 0030751205     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8581     Document Type: Article

References (46)

1. Adams E. M., Brown M. C., Nunge M., Krych M., Atkinson J. P. Contribution of the repeating domains of membrane cofactor protein (MCP; CD46) of the complement system to ligand binding and cofactor activity. J. Immunol. 147:1991;3005-3011.
2. Barlow P., Steinkasserer A., Norman D. B., Kieffer B., Wiles A. P., Sim R. B., Campbell I. D. Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232:1993;268-284.
3. Barlow P. N., Baron M., Norman D. G., Day A. J., Willis A. C., Sim R. B., Campbell I. D. Secondary structure of a complement control protein module by two-dimensional 1-H NMR. Biochemistry. 30:1991;997-1004.
4. Barlow P. N., Norman D. G., Steinkasserer A., Horne T. J., Pearce J., Driscoll P., Sim R. B., Campbell I. D. Solution structure of the fifth repeat of factor H: A second example of the complement control protein module. Biochemistry. 31:1992;3626-3634.
5. Bloom B. R. Vaccines for the third world. Nature. 342:1989;115-120.
6. Buchholz C., Schneider U., Devaux P., Gerlier D., Cattaneo R. Cell entry by measles virus: Long hybrid receptors uncouple binding from membrane fusion. J. Virol. 70:1996;3716-3723.
7. Carson M. RIBBONS 2.0. J. Appl. Crystallogr. 24:1991;958-961.
8. Cho S.-W., Oglesby T. J., Hsi B.-L., Adams E. M., Atkinson J. P. Characterization of three monoclonal antibodies to membrane cofactor protein (MCP) of the complement system and quantitation of MCP by radioassay. Clin. Exp. Immunol. 83:1991;257-261.
9. Devaux P., Loveland B., Christiansen D., Milland J., Gerlier D. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J. Gen. Virol. 77:1996;1477-1481.
10. Dorig R., Marcel A., Chopra A., Richardson C. D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:1993;295-305.
11. Ferrin T. E., Huant C. C., Jarvis L. E., Langridge R. The MIDAS display system. J. Mol. Graphics. 6:1988;13-27.
12. Gairin J. E., Oldstone M. B. Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: Implications for control of viral disease. J. Virol. 66:1992;6755-6762.
13. Gellin B. G., Katz S. L. Measles: State of the art and future directions. J. Infect. Dis. 170-S1:1994;3-14.
14. Griffin D. E., Bellini W. J. Measles virus. Virology. 1996;Lippincott-Raven, Philadelphia. p. 1267-1312.
15. Gunning P., Leavitt J., Muscat G., Ng S.-Y., Kedes L. Human B-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA. 84:1987;4831-4835.
16. Hourcade D., Holers V. M., Atkinson J. P. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 6:1989;381-416.
17. Huang C. C., Pettersen E. F., Klein T. E., Ferrin T. E., Langridge R. Conic: A fast renderer for space-filling molecules with shadows. J. Mol. Graphics. 9:1991;230-236.
18. Hummel B. K., Bellini W. J. Localization of antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J. Virol. 69:1995;1913-1916.
19. Iwata K., Seya T., Yanagi Y., Pesando J., Johnson P., Okabe M., Ueda S., Ariga H., Nagasawa S. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J. Biol. Chem. 270:1995;15148-15152.
20. Jones T. A., Zhou J. Y., Cowan S. W., Kjeldaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A47:1991;110-119.
21. Karp C., Wysocka M., Wahl L., Ahearn J., Cuomo P., Sherry B., Trinchieri G., Griffin D. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 273:1996;228-231.
22. Katz S. L., Gellin B. G. Measles vaccine: Do we need new vaccines or new programs? Science. 265:1994;1391-1392.
23. Krantic S., Gimenez C., Rabourdin-Combe C. Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation. J. Gen. Virol. 76:1995;2793-2800.
24. Krych M., Clemenza L., Howdeshell D., Hauhart R., Hourcade D., Atkinson J. P. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J. Biol. Chem. 269:1994;13272-13278.
25. Krych M., Hourcade D., Atkinson J. P. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc. Natl. Acad. Sci. USA. 88:1991;4353-4357.
26. Lecouturier V., Fayolle J., Caballero M., Carabana J., Celma M., Fernandez-Munoz R., Wild T., Buckland R. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: Phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 70:1996;4200-4204.
27. Liszewski M. K., Post T. W., Atkinson J. P. Membrane cofactor protein (MCP or CD46): Newest member of the regulators of complement activation gene cluster. Ann. Rev. Immunol. 9:1991;431-455.
28. Maisner A., Alvarez J., Liszewski M., Atkinson J., Herrler G. The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor. J. Virol. 70:1996;4973-4977.
29. Maisner A., Herrler G. Membrane cofactor protein with different types of N-glycans can serve as measles virus receptor. Virology. 210:1995;479-481.
30. Maisner A., Schneider-Schaulies J., Liszewski M. K., Atkinson J. P., Herrler G. Binding of measles virus to membrane cofactor protein (CD46): Importance of disulfide bonds and N-glycans for the receptor function. J. Virol. 68:1994;6299-6304.
31. Manchester M., Liszewski M. K., Atkinson J. P., Oldstone M. B. A. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc. Natl. Acad. Sci. USA. 91:1994;2161-2165.
32. Manchester M., Valsamakis A., Kaufman R., Liszewski M. K., Atkinson J. P., Lublin D. M., Oldstone M. B. A. Measles virus and C3 binding sites are distinct on membrane cofactor protein (MCP; CD46). Proc. Natl. Acad. Sci. USA. 92:1995;2303-2307.
33. Molina H., Kinoshita T., Webster C. B., Holers V. M. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153:1994;789-795.
34. Molina H., Perkins S. J., Guthridge J., Gorka J., Kinoshita T., Holers V. M. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules. J. Immunol. 154:1995;5426-5435.
35. Naniche D., Varior-Krishnan G., Cervino F., Wild T. F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:1993;6025-6032.
36. Norrby E., Gollmar Y. Identification of measles virus-specific hemolysis-inhibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect. Immunity. 11:1975;231-239.
37. Norrby E., Oxman M. Measles virus. Fields B. N., Knipe D. M. Virology. 1990;1013-1045 Raven, New York.
38. Nussbaum O., Broder C. C., Moss B., Bar-Lev Stern L., Rozenblatt S., Berger E. A. Functional and structural interaction between measles virus hemagglutinin and CD46. J. Virol. 69:1995;3341-3349.
39. Oglesby T. J., White D., Tedja I., Liszewski K., Wright L., Van den Bogarde J., Atkinson J. P. Protection of mammalian cells from complement (C)-mediated lysis by transfection of human membrane cofactor protein (MCP) and decay accelerating factor (DAF). Clin. Res. 39:1991;251A.
40. Oldstone M. B., Lewicki H., Borrow P., Hudrisier D., Gairin J. E. Discriminated selection among viral peptides with the appropriate anchor residues: Implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J. Virol. 69:1995;7423-7429.
41. Schneider-Schaulies J., Schnorr J., Schlender J., Dunster L., Schneider-Schaulies S., ter Meulen V. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. J. Virol. 70:1996;255-263.
42. Schneider-Schaulies J., Schnorr J.-J., Brinckmann U., Dunster L. M., Baczko K., Schneider-Schaulies S., terMeulen V. Receptor usage and differential downregulation of CD46 by measles virus wild type and vaccine strains. Proc. Natl. Acad. Sci. USA. 92:1995;3943-3947.
43. Schnorr J.-J., Dunster L. M., Nanan R., Schneider-Schaulies J., Schneider-Schaulies S., terMeulen V. Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur. J. Immunol. 25:1995;976-984.
44. Seya T., Kurita M., Tara T., Iwata K., Semba T., Hatanaka M., Matsumoto M., Yanagi Y., Ueda S., Nagasawa S. Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46). Immunology. 84:1995;619-625.
45. Seya T., Turner J., Atkinson J. P. Purification and characterization of a membrane protein (gp45-70) which is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163:1986;837.
46. Wild T. F., Malvoisin E., Buckland R. Measles virus: Both the hemagglutinin and fusion glycoproteins are required for fusion. J. Gen. Virol. 72:1991;439-442.